Investor Relations
We have developed a strong portfolio of patented technologies and products for enhancing the health and well-being of humans and animals. Our unique and innovative antimicrobial membrane technologies used in our air filtration products, surgical masks and respirators differentiate us from our competitors in a rapidly growing global market. We are also expanding our line of high quality, cutting-edge, portable animal ultrasound scanners for use in human medicine.
We are committed to becoming a market leader by enhancing our existing technologies and products, designing innovative new applications, licensing production of our antimicrobial products and hand sanitizers to independent partners; and, by expanding our proprietary and partner distributor networks globally.
Recent Press Releases
Noveko | TSX:EKO
| C$ | 0.25 |
| Daily High/Low | 0.25 / 0.24 |
| 52 Week High/Low | 1.00 / 0.22 |
| Market Cap | 22986500 |
| Shares Outstanding | 91946000 |
Quotes delayed at least 20 mins.
Contact Information
Investor Relations
Chantal Vennat
1155, René-Lévesque Blvd. West
Suite 1900
Montréal, Québec H3B 4V2
Canada
Telephone: 514.875.0606
Fax: 514.875.0660
cvennat@noveko.com
Transfer Agent
Computershare Investor Services 100 University Avenue
1500 University Street
Suite 700
Montréal (Québec)
H3A 3S8, Canada
9th Floor
Toronto (Ontario)
M5J 2Y1, Canada
Toll Free: 1.800.564.6253
General Inquires
Click here to contact us